ABT

Abbott Laboratories

Healthcare · USD

ABT

Price

$102.3

-0.55%

Cap

$178.4B

Earnings

2/4 beat

30d Trend

-1%

ABT
Loading chart data...
0 data pointsPowered by Brain47
52-week range4%
100.88139.06

Near 52-week lows — potential value or falling knife

Analyst consensus (16 analysts)+32% to target
0 Strong Buy14 Buy2 Hold0 Sell0 Strong Sell

Target range: $122$158 (consensus: $135.46)

Consensus: Buy

Earnings history

Q4 2025

MET

1.5 vs 1.5

Q3 2025

MET

1.3 vs 1.3

Q2 2025

BEAT

1.26 vs 1.25

Q1 2025

BEAT

1.09 vs 1.07

VolatilityLow

Key macro factors

·

Global macroeconomic conditions, including inflation, labor shortages, and geopolitical risks, which can impact Abbott's extensive international operations and supply chains.

·

The evolving regulatory landscape and increasing healthcare cost containment pressures from governments and private organizations, potentially affecting product pricing and market access.

·

Ongoing innovation and intense competition within the medical device and diagnostics sector, requiring continuous R&D investment and product differentiation for market share.

Abbott Laboratories is a global healthcare company with headquarters in Abbott Park, Illinois, known for its innovative solutions in diagnostics, medical devices, nutrition, and pharmaceuticals, operating in over 160 countries.

Next earnings:2026-04-16

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

Abbott Laboratories (ABT) — Brain47 AI Score 50/100 | Analysis